However, several studies have suggested that BCAA supplementation in patients with compensated cirrhosis and albumin levels greater than 3.6 g/dL or with a BTR of 4 or less may prevent a future drop in albumin [30,57]. This evidence concerns the gene ALB and Cirrhosis.